4th EACTS Mechanical Circulatory Support Summit

The 4th EACTS Mechanical Circulatory Support Summit will run from 7-9 November 2019 THURSDAY 7 NOVEMBER (08:00-18:00) 08:00 Welcome V Falk, Berlin; J Gummert, Bad Oeynhausen; I Netuka, Prague 08:15 Session 1: A heart failure therapy continuum and transplantation conundrums Moderators: V Falk, Berlin; J Cowger, Detroit Drugs, clips and LVADs: How to avoid a … Continue reading "4th EACTS Mechanical Circulatory Support Summit"

The 4th EACTS Mechanical Circulatory Support Summit will run from 7-9 November 2019

THURSDAY 7 NOVEMBER (08:00-18:00)
08:00 Welcome V Falk, Berlin; J Gummert, Bad Oeynhausen; I Netuka, Prague
08:15 Session 1: A heart failure therapy continuum and transplantation conundrums
Moderators: V Falk, Berlin; J Cowger, Detroit
Drugs, clips and LVADs: How to avoid a disconnect in heart failure therapies U Jorde, New York
Tablets on top of LVADs – what is an optimal medical therapy after the implant? M Cikes, Zagreb
Should we transplant stable LVAD patients – if and when to start the immunoreaction clock ticking H Reichensprunner, Hamburg
Lessons learned from the new UNOS allocation system F Pagani, Ann Arbor
Direct ECMO to heart transplantation strategy, the European experience P Leprince, Paris
Panel discussion
10:00 Break
10:30 EACTS MCS Lifetime Recognition Award
10:45 Session 2: Registries, guidelines and upcoming endeavors
Moderators: M Mehra, Boston; I Netuka, Prague
Europe, Quo Vadis? – the EUROMACS report T De By, The Hague
Pearls and diamonds of the EACTS Expert Consensus on MCS F Gustafsson, Copenhagen
What has IMACS taught us about patient outcomes with durable MCS? J Cowger, Detroit
Inferences of the MEDAMACS on an optimal timing of an LVAD implant G Stewart, Boston
Panel discussion
Featured lecture: Artificial intelligence, machine learning and beyond – Implications for cardiovascular medicine A Meyer, Berlin
12:15 Lunch
13:15 Session 3: Joint EACTS MCS & EURO-ELSO Scientific Symposium
Moderator: J Belohlavek, Prague; P Ostadal, Prague
Extended cardiopulmonary resuscitation (CPR) for refractory cardiac arrest J Belohlavek, Prague
New arms for cardiopulmonary resuscitation: Light at the end of the tunnel? C Benk, Freiburg
Venoarterial (VA) ECLS in cardiogenic shock – still an ongoing debate S Finney, London
Different ECLS configurations in postcardiotomy shock R Lorusso, Maastricht
Direct transition from ECLS to durable LVADs F Hennig, Berlin
Panel discussion
14:45 Session 4: Changing paradigms in cardiogenic shock – New tools, groundbreaking strategies
Moderator: H Reichensprunner, Hamburg
Staged escalation of transaortic left ventricular unloading – a partial flow is good enough F Papalardo, Milan
ECLS de-escalation strategies with transaortic MCS – full flow ahead D Saeed, Leipzig
Optimal device selection in cardiogenic shock – I do it my way E Potapov, Berlin
A quest towards longer-term transaortic MCS – promises and perils A Bernhardt, Hamburg
Panel discussion
16:15 Break
16:45 Session 5: Novel integrated approaches and technologies in MCS space
Moderator: V Falk, Berlin
Sensors in general and basic science To be announced
A true need for permanent wearables in LVADs? A new reality of unholstered device operation M Zilberschlag, Tel Aviv
A wealth of data and clinical implications of LVAD log files T Schlogelhofer, Vienna
What will the next generation LVAD look like? (Industry perspetive) K Bourque, Burlington
What will the next generation LVAD look like? (Industry perspetive) To be announced
Panel discussion
18:15 Close
Welcome reception (18:15-19:30)
FRIDAY 8 NOVEMBER (08:00-18:45)
08:00 Session 1: Perioperative challenges and evolving implant strategies
Moderator: R John, Minneapolis
How should we optimise with redo cases? Tricks and caveats M Morshuis, Bad Oeynhausen
Indications for intervention to manage aortic insufficiency – perioperative and on support R John, Minneapolis
Durable LVAD exchanges and upgrades J Schmitto, Hannover
Cardiopulmonary bypass in oblivion – ECLS facilitated LVAD implant G Färber, Jena
Cardiopulmonary bypass in oblivion – transaortic MCS facilitated LVAD implant D Zimpfer, Vienna
Off-pump LVAD implant. Is there a right time for a primetime? E Potapov, Berlin
Panel discussion
09:30 Session 2: Hemocompatibility – a new established entity in MCS landscape
Moderators: F Gustafsson, Copenhagen; U Jorde, New York
Hemocompatibility related adverse events To be announced
Strokes and LVADs – characteristic features and treatment strategies C Schulze, Jena
Indication of dependent and independent vitamin K antagonist (VKA) withdrawal in contemporary LVADs I Netuka, Prague
The future of LVAD therapy through the lens of a hematologist J M Connors, Boston
Panel discussion
10:40 Break
11:00 Session 3: The judgement of Paris: How do I choose the optimal pump for my patients?
Moderators: J Gummert, Bad Oeynhausen; F Pagani, Ann Arbor
Presentation 1 J Lavee, Tel Aviv
Presentation 2 C Mahr, Seattle
Presentation 3 C Selzman, Salt Lake City
Panel discussion
12:00 Keynote: Integrative approach in overcoming residual risks of LVADs towards the equipoise with the heart transplant M Mehra, Boston
12:30 Lunch
13:30 4th Rising Stars Quiz
14:30 Session 4: The right ventricle challenge
Moderator: J Katz, Chapel Hill
Longitudinal performance of the right ventricle through a magnifying glass V Melenovsky, Prague
Right ventricular (RV) failure – isolated issue or a peril of interwoven complexity? E Rame, Pennsylvania
Evolving trends in treatment of early RV failure D Schibilsky, Freiburg
Late right ventricular failure – now what? R Schramm, Bad Oeyenhausen
Panel discussion
15:35 Session 5: Boon and bane of biventricular MCS solutions – when both ventricles are done
Moderator: M Morshuis, Bad Oeynhausen
Chronic biventricular solution indications: Who, When, How? J Katz, Chapel Hill
RV dysfunction: Biventricular continuous flow pumps, total artificial heart (TAH) or paracorporeal devices – what is better? J Gummert, Bad Oeynhausen
Results with TAH are not superior to BiVAD in patients with severe RV dysfunction R John, Minneapolis
New TAH alternatives: Pulsatile or continuous flow? P Ivak, Prague
Panel discussion
16:30 Break
16:50 Session 6: From the new world: Unorthodox and creative solutions – How to get into or out of trouble
Moderator: J Garbade, Leipzig; E Potapov, Berlin; D Zimpfer, Vienna
Presentation 1 R John, Minneapolis
Presentation 2 F Pagani, Ann Arbor
Presentation 3 C Selzman, Salt Lake City
17:20 Session 7: Cardiac reverse remodeling and recovery in MCS – State of the art
Moderator: C Selzman, Salt Lake City
Recovery on acute MCS – wait, wean or transition…When and how? R Cogswell, Minneapolis
LVAD explantation for cardiac recovery – who and when? U Jorde, New York
The role of mitral regurgitation in sustainable LV recovery – fix it, clip later or simply ignore J Mulzer, Berlin
Preliminary results of multicenter evaluation of plug use for LVAD explantation E Potapov, Berlin
The future of cardiac recovery in MCS space – 30 000 feet perspective J Stehlik, Salt Lake City
Panel discussion
18:45 Close
SATURDAY 9 NOVEMBER (08:00-14:00)
08:00 Session 1: Challenging populations and expanding horizons in heart failure landscape
Pitfalls of durable MCS in GUCH population M Schweiger, Zurich
Surgical planning in complex anatomies B Meyns, Leuven
Optimised utilization of potential donor hearts – ex-vivo graft reconditioning R Venkateswaran, Manchester
An ultimate frontier – DCD donor utilization for heart transplantation S Tsui, Cambridge
Panel discussion
09:00 Session 2: Electrons, leads, devices and arrhythmia management in MCS
Moderator: C Mahr, Seattle
CIEDs in LVAD patients – PM, CRT, ICD J Vierecke, Ohio
Transvenous lead extraction in LVAD patients – when, why and how? E Potapov, Berlin
Implantable cardiac monitoring systems in LVAD population F Schönrath, Berlin
Supraventricular and ventricular arrhythmia management in MCS recipients J Kautzner, Prague
Panel discussion
10:00 Break
10:30 Session 3: Small improvements, a major impact?
Moderator: M Zembala, Zabrze
Thrombus formation around inflow canula of CF-Pumps – interplay of a position and hemodynamics F Kaufmann, Berlin
Optimising inflow cannula position by 3D preop rendering I Hartyanszky, Budapest
Background and outlook on the usage of cold atmospheric plasma (CAP) in medicine K Masur, Greifswald
CAP: An additive treatment option for critical wounds in cardiovascular surgery L Hilker, Karlsburg
Critical VAD exit site wounds – (Case series) M Konarik, Prague
Panel discussion
11:30 Session 4: From the old world: Unorthodox and creative solutions – How to get into or out of trouble
Pericardial tamponade after LVAD implantation through left lateral thoracotomy P Lanmueller, Berlin
Presentation 2 I Knezevic, Ljubljana
Presentation 3 G Gerosa, Padua
Presentation 4 A Loforte, Bologna
Presentation 5 M Morshuis, Bad Oeynhausen
Presentation 6 J Maly, Prague
12:30 Session 5: Update of current and upcoming devices
13:45 Closing Remarks

 

Programme and faculty subject to change

COURSE INFORMATION

Date/Duration
7-9 November 2019 (3 day course)

Location
Prague, Czech Republic
Please click HERE for more information

Chairmen
I Netuka, Prague; V Falk, Berlin and J Gummert, Bad Oeynhausen

Registration Fee

Members: €550 inclusive of VAT
Non-Members: €650 inclusive of VAT

Course fee includes lunch and refreshments on all days and the welcome reception on Thursday 7 November

Summit Format
Interactive lectures, live-in-a-box cases and keynote presentations

Target Audience
Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and ventricular assist device (VAD) coordinators, medical industry (cardiac devices including ECMO development and production). Paediatric cardiologists and congenital heart disease surgeon.

Learning Objectives

  • Learn about how to find the right treatment for the right patient at the right time
  • Use of temporary MCS systems in emergency situations and in the ICU
  • Learning of recommendations for VAD use from major societies and from recently published guidelines
  • New surgical techniques for VAD implantation, as well as unusual solutions of complex surgical problems in VAD patients
  • How to avoid long-term complications during VAD treatment
  • Learn about shared care and the role of social media for VAD patients and caregivers
  • Learn about myocardial recovery in children and adults
  • Review and learn about the latest developments and perspectives in the VAD field